Dr. Sushma Reddy, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 5744 Lakeshore Rd, Fort Gratiot, MI 48059 Phone: 586-871-0473 Fax: 810-385-9216 |
Rashim K Gupta, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4190 24th Ave, Suite 206, Fort Gratiot, MI 48059 Phone: 810-989-7478 Fax: 810-989-7644 |
Butheinah A Al-sharafi, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4190 24th Ave, Suite:201, Fort Gratiot, MI 48059 Phone: 810-989-7478 Fax: 810-989-7644 |
News Archive
A team of researchers from the Spanish National Cancer Research Centre (CNIO), headed by CNIO Director Mar-a Blasco, has demonstrated in a pioneering study on mammals that longevity is defined at a molecular level by the length of telomeres. The work-which is published today in the online edition of the journal Cell Reports-opens the door to further study of these cellular components in order to calculate the rate at which cells age and thus be able to determine life expectancy for a particular organism.
"South Africa faces significant challenges when it comes to sexual health, and with the high prevalence of rape, teen pregnancy, and sexually transmitted diseases and infections, schools need to implement strong and informative programs on sexuality and contraceptive use," Jos Dirkx, founder of Girls & Football SA, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
"Even as the world's deadline for" reaching the "Millennium Development Goals approaches in 2015, countries are not making water and sanitation a priority, which in turn impacts other developmental goals like health and education," according to a WHO report released Wednesday, Press Trust International/Business Standard reports (4/22).
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
› Verified 2 days ago